A carregar...
Uptake of the First Biosimilar Infliximab since its Approval in South Korea
OBJECTIVE: FDA is considering an application for a biosimilar infliximab, which has been available in South Korea since November 2012. We aimed to examine the utilization patterns of both branded and biosimilar infliximab and other TNF in South Korea before and after the introduction of biosimilar i...
Na minha lista:
| Publicado no: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4848142/ https://ncbi.nlm.nih.gov/pubmed/26662931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39546 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|